Supportive therapy in medical therapy of head and neck tumors.

about

Supportive therapy in medical therapy of head and neck tumors.

Item

http://www.wikidata.org/entity/Q36529853

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Supportive therapy in medical therapy of head and neck tumors.

@ast

Supportive therapy in medical therapy of head and neck tumors.

@en

type

Item

label

Supportive therapy in medical therapy of head and neck tumors.

@ast

Supportive therapy in medical therapy of head and neck tumors.

@en

prefLabel

Supportive therapy in medical therapy of head and neck tumors.

@ast

Supportive therapy in medical therapy of head and neck tumors.

@en

P1476

Supportive therapy in medical therapy of head and neck tumors.

@en

P2093

Hartmut Link

http://www.w3.org/2001/XMLSchema#string

P2860

September 2007 Update on EORTC Guidelines and Anemia Management with Erythropoiesis-Stimulating Agents

Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial.

Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study.

American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management.

Antiemetics: American Society of Clinical Oncology clinical practice guideline update.

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis.

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.

P304

Doc01

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3205/CTO000083

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23320053

http://www.w3.org/2001/XMLSchema#string

P932

3544209

http://www.w3.org/2001/XMLSchema#string